Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Clyra Medical Technology Inc [Member] Common Stock [Member]	Clyra Medical Technology Inc [Member] Additional Paid-in Capital [Member]	Clyra Medical Technology Inc [Member] Retained Earnings [Member]	Clyra Medical Technology Inc [Member] AOCI Attributable to Parent [Member]	Clyra Medical Technology Inc [Member] Noncontrolling Interest [Member]	Clyra Medical Technology Inc [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2019							166,256,024
Balance at Dec. 31, 2019							$ 111,000	$ 121,327,000	$ (123,492,000)	$ (99,000)	$ (27,000)	$ (2,180,000)
Sale of common stock for cash (in shares)							4,848,305
Sale of common stock for cash							$ 3,000	898,000	0	0	0	901,000
Issuance of common stock for service (in shares)							1,039,490
Issuance of common stock for service							$ 1,000	177,000	0	0	0	178,000
Stock option compensation expense	$ 0	$ 420,000	$ 0	$ 0	$ 0	$ 420,000	0	320,000	0	0	0	320,000
Clyra Medical securities offering	0	15,000	0	0	10,000	25,000
Net loss							$ 0	0	(2,274,000)	0	(342,000)	(2,616,000)
Conversion of notes (in shares)							3,387,649
Conversion of notes							$ 2,000	432,000	0	0	0	434,000
Issuance of common stock for interest (in shares)							19,278
Issuance of common stock for interest							$ 0	4,000	0	0	0	4,000
Balance (in shares) at Mar. 31, 2020							178,479,317
Balance at Mar. 31, 2020							$ 119,000	123,121,000	(125,866,000)	(99,000)	89,000	(2,636,000)
Common stock issued as a financing fee; deferred offering costs (in shares)							2,928,571
Common stock issued as a financing fee; deferred offering costs							$ 2,000	(124,000)	0	0	0	(122,000)
Deemed dividend for the change in accounting for derivative liability							0	100,000	(100,000)	0	0	0
Allocation of noncontrolling interest from Clyra Stock option issuance							$ 0	(448,000)	0	0	448,000	0
Balance (in shares) at Dec. 31, 2019							166,256,024
Balance at Dec. 31, 2019							$ 111,000	121,327,000	(123,492,000)	(99,000)	(27,000)	(2,180,000)
Net loss												(5,316,000)
Foreign currency translation												22,000
Foreign currency translation												22,000
Balance (in shares) at Jun. 30, 2020							190,703,381
Balance at Jun. 30, 2020							$ 128,000	130,875,000	(128,292,000)	(77,000)	(4,239,000)	(1,605,000)
Balance (in shares) at Mar. 31, 2020							178,479,317
Balance at Mar. 31, 2020							$ 119,000	123,121,000	(125,866,000)	(99,000)	89,000	(2,636,000)
Sale of common stock for cash (in shares)							3,689,246
Sale of common stock for cash							$ 2,000	558,000	0	0	0	560,000
Issuance of common stock for service (in shares)							1,774,033
Issuance of common stock for service							$ 1,000	271,000	0	0	0	272,000
Stock option compensation expense	0	20,000	0	0	0	20,000	0	528,000	0	0	0	528,000
Noncontrolling interest allocation							0	4,401,000	0	0	(4,401,000)	0
Clyra Medical securities offering	0	476,000	0	0	348,000	824,000
Net loss							0	0	(2,426,000)	0	(275,000)	(2,701,000)
Foreign currency translation							$ 0	0	0	22,000	0	22,000
Conversion of notes (in shares)							6,463,784
Conversion of notes							$ 6,000	682,000	0	0	0	688,000
Issuance of common stock for interest (in shares)							297,001
Issuance of common stock for interest							$ 0	30,000	0	0	0	30,000
Foreign currency translation							$ 0	0	0	22,000	0	22,000
Balance (in shares) at Jun. 30, 2020							190,703,381
Balance at Jun. 30, 2020							$ 128,000	130,875,000	(128,292,000)	(77,000)	(4,239,000)	(1,605,000)
Clyra Medical stock for other asset (See Note 2)							$ 0	788,000	0	0	0	788,000
Balance (in shares) at Dec. 31, 2020							225,885,682
Balance at Dec. 31, 2020							$ 151,000	135,849,000	(132,041,000)	(101,000)	(4,093,000)	(235,000)
Sale of common stock for cash (in shares)							13,330,619
Sale of common stock for cash							$ 9,000	2,097,000	0	0	0	2,106,000
Issuance of common stock for service (in shares)							747,487
Issuance of common stock for service							$ 1,000	110,000	0	0	0	111,000
Stock option compensation expense	0	161,000	0	0	0	161,000	0	424,000	0	0	0	424,000
Warrants and conversion feature issued as discount on convertible note payable							0	35,000	0	0	0	35,000
Noncontrolling interest allocation							0	(313,000)	0	0	313,000	0
Clyra Medical securities offering	0	0	0	0	50,000	50,000
Net loss							0	0	(1,631,000)	0	(247,000)	(1,878,000)
Foreign currency translation							0	0	0	(2,000)	0	(2,000)
Foreign currency translation							$ 0	0	0	(2,000)	0	(2,000)
Balance (in shares) at Mar. 31, 2021							239,963,788
Balance at Mar. 31, 2021							$ 161,000	138,363,000	(133,672,000)	(103,000)	(3,977,000)	772,000
Balance (in shares) at Dec. 31, 2020							225,885,682
Balance at Dec. 31, 2020							$ 151,000	135,849,000	(132,041,000)	(101,000)	(4,093,000)	(235,000)
Net loss												(3,668,000)
Foreign currency translation												(2,000)
Foreign currency translation												(2,000)
Balance (in shares) at Jun. 30, 2021							250,996,373
Balance at Jun. 30, 2021							$ 168,000	140,292,000	(135,294,000)	(103,000)	(3,831,000)	1,232,000
Balance (in shares) at Mar. 31, 2021							239,963,788
Balance at Mar. 31, 2021							$ 161,000	138,363,000	(133,672,000)	(103,000)	(3,977,000)	772,000
Sale of common stock for cash (in shares)							8,627,237
Sale of common stock for cash							$ 6,000	1,408,000	0	0	0	1,414,000
Issuance of common stock for service (in shares)							357,132
Issuance of common stock for service							$ 0	60,000	0	0	0	60,000
Stock option compensation expense	$ 0	$ 102,000	$ 0	$ 0	$ 0	$ 102,000	0	330,000	0	0	0	330,000
Noncontrolling interest allocation							0	(314,000)	0	0	314,000	0
Net loss							0	0	(1,622,000)	0	(168,000)	(1,790,000)
Foreign currency translation							$ 0	0	0	0	0	0
Conversion of notes (in shares)							1,966,439
Conversion of notes							$ 1,000	327,000	0	0	0	328,000
Issuance of common stock for interest (in shares)							81,777
Issuance of common stock for interest							$ 0	16,000	0	0	0	16,000
Foreign currency translation							$ 0	0	0	0	0	0
Balance (in shares) at Jun. 30, 2021							250,996,373
Balance at Jun. 30, 2021							$ 168,000	$ 140,292,000	$ (135,294,000)	$ (103,000)	$ (3,831,000)	$ 1,232,000